GSK focuses on 3 priorities - Innovation, Performance, Trust

How we do it

Everyone at GSK focuses on 3 priorities - Innovation, Performance, Trust


We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.


global Research and Development centres based in India*


Regulatory platforms and delivery is located in India*

* not part of the local listed entity


We aim to achieve industry-leading growth by investing effectively in our business, developing our people and delivering flawlessly.


in vaccines self-pay segment


in Dermatology therapy area


brands in top 50 in the Indian Pharmaceuticals Market

Over ₹3000 crores

(around GBP 300 million) turnover as on 31st March 2019


We commit to ensuring the quality, safety and reliable supply of our products; and to building trust through our approach to engagement, pricing, global health and being a progressive employer.

12 billion

tablets and capsules manufactured to serve patients in India

Over 5,000

employees are proud to work at GlaxoSmithKline Pharmaceuticals Ltd.

3 billion

tablets donated to to the WHO for 'Partnering India to Eliminate Lymphatic Filariasis' since 2001


in Access to Medicines Index all 6 times since its launch in 2008

Our values and expectations are at the heart of everything we do and form an important part of our culture.

Values and expectations of GSK